15:00 Introduction
Pr P. Tsoutsou & Dr A. Durham
15:10 Current use of RT in the spectrum of heme malignancies
Pr J. Yahalom
15:30 Low grade lymphomas and very low dose RT
Pr J. Yahalom
16:15 RT for salvage; Focus on RT with CAR-T therapy
Pr J. Yahalom
17:00 RT in a new era of plasma cell neoplasm management
Dr A. Dreyfuss
17:50 ILROG mission of research and education
Pr J. Yahalom
18:00 Closing remarks & farewell
Pr P. Tsoutsou & Dr A. Durham
Chaque session inclut 5 à 10 minutes de discussion.